Daniel Marquess
62Patents
17h-index
36Co-inventors
84Inventor score
Filing activity: Dec 8, 1999 → Aug 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6693202B1 | Muscarinic receptor antagonists | Chemistry; Metallurgy | 138 | Expired |
| US7279458B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Chemistry; Metallurgy | 36 | Expired |
| US6878686B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6974797B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 29 | Expired |
| US7067482B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Chemistry; Metallurgy | 29 | Expired |
| US7067481B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 28 | Expired |
| US6995138B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Emerging Cross-Sectional Technologies | 26 | Expired |
| US7375114B2 | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists | Chemistry; Metallurgy | 22 | Active |
| US7655621B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 21 | Active |
| US7601690B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 20 | Active |
| US7649080B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 20 | Active |
| US7553962B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 19 | Active |
| US7341993B2 | Cross-linked glycopeptide—cephalosporin antibiotics | Human Necessities | 19 | Expired |
| US7332471B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 18 | Expired |
| US7396933B2 | Quinolinone-carboxamide compounds | Human Necessities | 18 | Expired |
| US7183323B2 | Sodium channel modulators | Chemistry; Metallurgy | 18 | Expired |
| US7612037B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 17 | Active |
| US7728127B2 | Cross-linked glycopeptide-cephalosporin antibiotics | Human Necessities | 17 | Active |
| US7399862B2 | 5-HT4 receptor agonist compounds | Human Necessities | 17 | Expired |
| US6646012B2 | Sodium channel modulators | Chemistry; Metallurgy | 16 | Expired |
| US6756400B2 | Sodium channel modulators | Chemistry; Metallurgy | 16 | Expired |
| US6479498B1 | Sodium channel drugs and uses | Human Necessities | 16 | Expired |
| US6420354B1 | Sodium channel drugs and uses | Physics | 16 | Expired |
| US7351704B2 | Indazole-carboxamide compounds as 5-HT4 receptor agonists | Physics | 14 | Active |
| US7317022B2 | Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists | Human Necessities | 12 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.